Date post: | 03-Dec-2023 |
Category: |
Documents |
Upload: | independent |
View: | 0 times |
Download: | 0 times |
December 2013, Vol. 7, No. 12, pp. 1228-1235 Journal of Life Sciences, ISSN 1934-7391, USA
Extramedullary Hematopoiesis Mimicking a Neoplasm in
a Goeldi’s Monkey (Callimico goeldii)
Rute Marina Noiva1, Hugo Pissarra1, Teresa Fernandes2, Rui Bernardino2, Luis Madeira de Carvalho1, Fernando
Alves Afonso1 and Maria Conceicao Peleteiro1
1. Interdisciplinary Research Centre on Animal Health, Faculty of Veterinary Medicine, Technical University of Lisbon
(CIISA/FMV/UTL), Avenida da Universidade Tecnica, Lisbon 1300-477, Portugal
2. Jardim Zoologico de Lisboa, Estrada de Benfica 158-160, Lisbon 1549-004, Portugal
Received: August 23, 2013 / Accepted: November 04, 2013 / Published: December 30, 2013. Abstract: Extramedullary hematopoiesis consists in the appearance and proliferation of hematopoietic cells outside the bone marrow. In
this article, the authors describe a case of hepatosplenic hematopoiesis in a 9-year-old, male Goeldi’s monkey concurrent with a
Calodium hepaticum infestation, belonging to the Lisbon’s Zoo primate collection (Portugal). Lesions were identified upon necropsy
after euthanasia due to the presence of an apparently non-excisable, metastatic aortic mass. Histopathological analysis of samples
taken was carried out and immunohistochemical staining was used to characterize the cellular population involved, confirming the
diagnosis of extramedullary hematopoiesis. To the best of the authors’ knowledge, this is the first report of hepatosplenic
extramedullary hematopoiesis in a Goeldi’s monkey.
Key words: Extramedullary hematopoiesis, Goeldi’s monkey, Callimico goeldii, Calodium hepaticum, liver, spleen.
1. Introduction
In the mature animals, homeostatic hematopoiesis is
confined to the marrow cavity of the flat bones and the
epiphysis of long bones [1]. EMH (extramedullary
hematopoiesis) is the typically asymptomatic
appearance of hematopoietic elements outside of the
bone marrow as a result of compensation for
hematopoietic malfunction, serious chronic anemia,
myelofibrosis, chronic myelocytic leukemia and
metastasis of malignant tumors to the bone marrow,
among other causes [2, 3].
Extramedullary hematopoiesis usually occurs in
tissues with an environment that supports the
proliferation of primitive hematopoietic bone marrow
elements [4]. The organs of the reticuloendothelial
system, like the liver, spleen and lymph nodes are the
sites most frequently involved, although, in humans,
Corresponding author: Rute Marina Noiva, Ph.D., research
field: veterinary pathology. E-mail: [email protected].
EMH has also been observed in the posterior
mediastinum, kidney, central nervous system and
peripheral nerves, meninges, middle ear, pancreas,
urethra, thyroid and adrenal glands, gastrointestinal
tract, pharynx, lung, pleura and pericardium, heart,
peritoneum and retroperitoneum, skin, kidney, breast,
ovary, prostate gland, endometrium, epididymis and
thymus [1, 3-6].
In humans, EMH often resembles more common
conditions such as benign or malignant
lymphadenopathy or a metastasis on radiographic
studies [3]. Ultrasound findings vary from solitary
heterogenous hypoechoic nodules to multiple
echogenic masses with central necrosis. Computerized
tomography findings are also variable, ranging from
multiple hypodense to solitary hyperdense masses [7].
In adult humans, hepatic EMH is seen in a variety
of conditions, including hematologic disorders, sepsis,
transplantation, massive hepatic necrosis, but is also
D DAVID PUBLISHING
Extramedullary Hematopoiesis Mimicking a Neoplasm in a Goeldi’s Monkey (Callimico goeldii)
1229
notably prominent within hepatoblastomas, hepatic
adenomas and hepatocellular carcinoma [8].
In new world monkeys, nodular foci of
extramedullary hematopoiesis and myelolipomas are
occasionally found in the spleen and liver. However,
the pathogenesis and significance of these foci is
unknown [9].
The current work aims at reporting a case
of extramedullary hematopoeisis mimicking a
metastatic neoplasm in a Goeldi’s monkey (Callimico
goeldii).
2. Materials and Methods
In November 2009, a 9-year-old male Goeldi’s
monkey (Callimico goeldii), belonging to the
zoological collection of the Lisbon’s Zoo (Portugal)
was taken for clinical examination, due to a 4-day
history of behavioural changes. The animal had been
increasingly unresponsive and spent progressively
longer periods of time on top of a heating unit. During
a routine clinical evaluation, the animal was found to
be thin in spite of a normal appetite and an otherwise
uneventful clinical history. A large abdominal mass
(about 4 cm in diameter) was detected in routine
abdominal palpation. Blood was collected for CBC
(complete blood count) and biochemical analysis,
which revealed anemia and mild leucocytosis with
monocytosis and lymphocytosis, along with elevated
billirrubin levels. Other complementary exams,
namely ultrasound, did not reveal the origin of the
abdominal mass but justified a strong suspicion of
aortic involvement.
Exploratory laparotomy revealed the aortic mass to
be impossible to remove and intra-surgical euthanasia
was decided upon.
The necropsy was carried out at the zoo’s medical
facilities and organ samples were sent to the
Laboratory of Pathological Anatomy and to the
Laboratory of Parasitology of the FMV/UTL, for
histopathological and parasitological analysis.
Immunostaining was performed for specific
myeloid and lymphoid markers, using the following
antibodies: CD3 (Dako, polyclonal), Pax5
(Novocastra, monoclonal), Macrophages/Monocytes
(AbDSerotec, monoclonal), Myeloperoxidase (Dako,
polyclonal), CD10 (Zymed, monoclonal), CD20cy
(Dako, monoclonal), light λ-chains (Dako, polyclonal)
and CD117 (Dako, polyclonal).
A commercial labelling system was used with the
NovolinkTM Polymer (Novocastra).
3. Results
At necropsy, the 4 cm abdominal mass was shown
to envelope a section of the abdominal aorta. All other
organs appeared unchanged, except for the liver which
exhibited a pale nodule and several scattered
yellowish spots, and the spleen which appeared
diffusely enlarged.
Histopathology revealed the aortic mass to be a
collection of fibrinous exudate arranged in layers and
enveloped by a congestive fibrous capsule (Fig. 1).
Histochemical staining with PAS (periodic acid-Schiff
stain) revealed several organisms consistent with
yeasts, sometimes arranged in pseudohyphae, within
the mass.
The pale liver nodule corresponded to infiltration of
the hepatic parenchyma by hematopoietic precursor
cells with disruption of the normal hepatic architecture,
while the yellowish spots were found to be
granulomas surrounding nematode eggs.
Parasitological analysis of liver samples identified the
eggs to be from Calodium hepaticum. Adult forms of
the nematode were also visible in histological liver
sections. PAS staining revealed microorganisms
similar to those present in the aortic mass in the serosa
lining the liver, spleen, kidney and intestine.
The splenomegaly was due to infiltration by
hematopoietic precursor cells similar (although
less extensive) to that observed in the liver, along
with moderate hyperplasia of the white splenic
pulp.
Immunostaining for specific myeloid and lymphoid
Extramedullary Hematopoiesis Mimicking a Neoplasm in a Goeldi’s Monkey (Callimico goeldii)
1230
Fig. 1 Photomicrographs of necropsy samples (Hematoxylin & Eosin). (A) and (B) Liver sections exhibiting marked infiltration by hematopoietic cells, among which megakaryocytes are the most flagrant example (*). Calodium hepaticum eggs
can also be identified (arrow) (40 and 100); (C) Spleen section with multifocal infiltration by hematopoietic cells (40); (D)
External surface of the thick fibrous capsule surrounding the aortic mass, with focal calcification and infiltration by
inflammatory cells (40), Inset: Several yeasts within the fibrinous exudate of the aortic mass (PAS, 400).
markers revealed that the cellular population in the
liver and spleen was heterogenous in nature and
compatible with a diagnosis of hepatosplenic
extramedullary hematopoiesis. Table 1 summarizes
the results obtained upon immunostaining for both the
lymphoid and myeloid markers mentioned, namely in
what concerns the intensity of marker expression
(reflecting percentage of cells marked and intensity of
staining) and the pattern of distribution of positive
cells within both hepatic and splenic parenchyma.
Figs. 2-6 illustrate areas of stained tissues
representative of the overall positive cell distribution
for each marker in the liver and spleen. As it can be
estimated from both images and table, the positively
marked cells are distributed through the affected aeas
of the hepatic parenchyma in a diffuse manner,
without any discernible pattern. Most of the cells
expressed lymphoid (CD3, CD20 and Pax5) and
macrophage/granulocyte (macrophage and
myeloperoxidase) surface markers, with no apparent
expression of neural crest/mastocyte markers (CD117).
Infiltrating positively marked cells exhibited a
different pattern of organization in the spleen, with the
lymphoid cells arranging themselves in a follicular
pattern similar to that usually seen in a healthy organ.
All other cells expressing the remaining markers
tested were found diffusely distributed through the
splenic parenchyma. Contrarily to the cellular
population infiltrating the liver, cells expressing
macrophage/granulocyte markers were less frequently
observed in the spleen. Again, no CD117-positive
cells were present.
Both kidneys exhibited multifocal interstitial
lymphocitic infiltrates and the presence of intratubular
hyaline cylinders, while the intestine showed MALT
hyperplasia.
Extramedullary Hematopoiesis Mimicking a Neoplasm in a Goeldi’s Monkey (Callimico goeldii)
1231
Fig. 2 Immunohistochemical staining of liver and spleen sections (NovolinkTM polymer, Mayer’s hematoxylin). (A) Liver,
CD3 marker (100); (B) Spleen, CD3 marker (100); (C) Liver, CD10 marker (100); (D) Spleen, CD10 marker (100).
Fig. 3 Immunohistochemical staining of liver and spleen sections (NovolinkTM polymer, Mayer’s hematoxylin). (A)
Liver, CD20 marker (100); (B) Spleen, CD20 marker (100); (C) Liver, CD117 marker (100); (D) Spleen, CD117
marker (100).
Extramedullary Hematopoiesis Mimicking a Neoplasm in a Goeldi’s Monkey (Callimico goeldii)
1232
Fig. 4 Immunohistochemical staining of liver and spleen sections (NovolinkTM polymer, Mayer’s hematoxylin). (A) Liver,
Lambda chains marker (100); (B) Spleen, Lambda chains marker (100); (C) Liver, Macrophage marker (100); (D) Spleen,
Macrophage marker (100).
Fig. 5 Immunohistochemical staining of liver and spleen sections (NovolinkTM polymer, Mayer’s hematoxylin). (A) Liver,
Myeloperoxidase marker (100); (B) Spleen, Myeloperoxidase marker (100); (C) Liver, Pax5 marker (100); (D) Spleen,
Pax5 marker (100).
Extramedullary Hematopoiesis Mimicking a Neoplasm in a Goeldi’s Monkey (Callimico goeldii)
1233
Fig. 6 Expression of the different immunohistochemical markers along the chain of hematopoietic differentiation [10, 11].
BFU-E: Burst Forming Unit-Erythroid Precursor; CFU: Colony Forming Unit; E: Erythroid; Eo: Eosinophil; G: Granulocyte; GEMM: Granulocyte, Erythrocyte, Monocyte, Megakaryocyte; GM: Granulocyte, Monocyte.
Table 1 Intensity and pattern of immunostaining of the infiltrating hematopoietic precursor cells in the liver and spleen.
Immunohistochemical marker Liver Spleen
Intensity Pattern Intensity Pattern
CD3 +++ Diffuse + Perivascular
CD10 + Diffuse +/- Diffuse
CD20 ++ Diffuse ++ Follicular
CD117 - - - -
Light-λ chains + Diffuse ++ Diffuse
Macrophage ++++ Diffuse + Diffuse
Myeloperoxidase +++ Diffuse + Diffuse
Pax5 ++ Diffuse ++ Follicular
4. Discussion
Extramedullary hematopoiesis results when there is
hormonal induction for increased cell production and
pluripotential hematopoietic stem cells available.
These cells normally circulate in very low numbers
and, in preparation for extramedullary hematopoiesis,
they return to embryonic sites of colonization, sparing
the germinal centers and periarteriolar lymphoid
sheaths [12].
In general, three situations underlie the abnormal,
extramedullary proliferation of normal hematopoietic
elements: filtration, where immature cells are trapped
by the spleen or other sites and proliferate; inadequate
marrow space to produce appropriate numbers of
marrow elements or damage to the bone marrow
microenvironment leading to increased numbers of
circulating hematopoietic stem cells; and abnormal
cytokine or other circulating hematopoietic growth
factors causing stem cell differentiation to
hematopoietic cells or local effects simulating the
marrow microenvironment. The third cause may occur
independently as a result of hematopoietic growth
factors production by a tumor or at sites of tissue
Extramedullary Hematopoiesis Mimicking a Neoplasm in a Goeldi’s Monkey (Callimico goeldii)
1234
damage and repair [1, 8]. In human adults, hepatic
EMH is seen in a variety of conditions, including
hematologic disorders, sepsis, transplantation, massive
hepatic necrosis, but is also notably prominent within
hepatoblastomas, hepatic adenomas and hepatocellular
carcinoma. The cause of these proliferations is not
well understood, and may be due to local hypoxic
conditions, local effects of tumors that simulate the
embryonic liver and are supportive of hematopoietic
development, or production of growth factors that
attract and/or support hematopoiesis [8]. When
anemia is excessively prolonged and severe, there may
be some degree of extramedullary hematopoiesis by
the liver and spleen [13].
The organs of the reticuloendothelial system, like
the liver, spleen and lymph nodes are the preferential
target organs for EMH, while the most common site
involved by non hepatosplenic EMH in humans seems
to be in or surrounding the vertebral column [4, 5].
Other preferential sites include the inguinal,
para-aortic, cervical and paratracheal lymph nodes;
the retroperitoneum; the lungs, pleura or both; the
genitourinary system; the skin; the right thalamus, the
right atrium of the heart; the oral mucosa and the
rectus femoris muscle, in that order [5].
Extramedullary hematopoiesis is characteristically
trilineage [12]. In the liver, it can appear as
focal aggregates of myeloid cells in the perisinusoidal
compartment as this area retains its embryonic
hospitality for EMH throughout the animal’s
life [12-14].
Megakaryocytes are the most obvious
hematopoietic precursor and characteristically lie
adjacent to the smooth muscle splenic trabeculae
when stimulation is mild, but may become diffusely
distributed in the sinus areas when stimuli are
pronounced and prolonged [12].
In the case here described, extramedullary
hematopoiesis was restricted to the liver and spleen. It
was not possible, in this case, to determine the
primary cause for the aortic mass.
EMH is a frequent finding in human patients
undergoing liver transplantation for massive hepatic
necrosis. This may also be a consequence of the
anaemia associated with this condition. Alternatively,
there may be a possibility that intrahepatic
hematopoiesis is linked with hepatopoiesis [15]. In
this monkey’s case, although impossible to prove, it is
justified to theorize that the chronic and diffuse
hepatic aggression caused by the presence of the
numerous Calodium hepaticum granulomas (along
with all secondary effects associated to the infection),
in conjunction with the exuberant response to the
aortic mycotic infection, may have been the primary
stimulus for the development of EMH, possibly as an
organic compensatory mechanism. The lesions of
chronic interstitial nephritis would most likely have
contributed to the overall metabolic state of
dysfunction. Although most reported cases of
Calodium hepaticum infection in primates do not
mention extramedullary hematopoiesis, it is not
unreasonable to assume that these two conditions
might coexist in sporadic cases, especially if adjuvant
lesions are also present.
Clinically, non hepatosplenic-EMH may present as
an incidental finding or with a symptomatic disease or
condition, including pleural effusion, ascites,
neurologic deficit, cardiac tamponade, chronic renal
failure, acute respiratory failure, orbital proptosis and
subglottic stenosis. Antemortem diagnosis can be
made by tissue biopsy, FNA (fine needle aspiration)
biopsy, or radionuclide scanning [5].
Similarly, in the case here described all of the
animal’s clinical signs (progressive unresponsiveness
and weight loss without loss of appetite) and
complementary exam results (anemia and mild
leucocytosis with monocytosis and lymphocytosis,
and elevated bilirubin levels) were not indicative of
extramedullary hematopoiesis, but could easily be
attributed to the on-going concurrent conditions later
detected during necropsy and confirmed by
histopathological analysis.
Extramedullary Hematopoiesis Mimicking a Neoplasm in a Goeldi’s Monkey (Callimico goeldii)
1235
5. Conclusion
In humans, EMH often resembles more common
conditions such as benign or malignant
lymphadenopathy or a metastasis on radiographic
studies [3]. This report describes a case of
hepatosplenic extramedullary hematopoiesis
mimicking a metastatic paraaortic neoplasm with
hepatic and splenic involvement in a Goeldi’s monkey,
with particular emphasis on the immunohistochemical
phenotype of the cells involved in this condition. No
other published reports similar cases in these animals
were found up to the completion of this study
suggesting this might be the first of that kind.
References
[1] D. Bienzle, J.M. Kwiecien, J.M. Parent, Extramedullary
hematopoiesis in the choroid plexus of five dogs, Vet.
Pathol. 32 (4) (1995) 437-440.
[2] R. Mimura, T. Kamishima, K.C. Kubota, F. Nakano, I.
Yabe, H. Sasaki, et al., Extramedullary plasmacytoma
involving perirenal space accompanied by extramedullary
hematopoiesis and amyloid deposition, Jpn. J. Radiol. 28
(4) (2010) 309-313.
[3] F.I. Hsu, D.A. Filippa, H. Castro-Malaspina, R.J.
Downey, Extramedullary hematopoiesis mimicking
metastatic lung carcinoma, Ann. Thorac. Surg. 66 (4)
(1998) 1411-1413.
[4] J.D. Coyne, Extramedullary haemopoiesis, J. Clin. Pathol.
58 (4) (2005) 448. [5] C.A. Koch, C.Y. Li, R.A. Mesa, A. Tefferi,
Nonhepatosplenic extramedullary hematopoiesis: Associated diseases, pathology, clinical course and treatment, Mayo. Clin. Proc. 78 (10) (2003) 1223-1233.
[6] M.D. Wiener, R.A. Jr. Halvorsen, R.T. Vollmer, W.L. Foster, L. Jr. Roberts, Focal intrahepatic extramedullary hematopoiesis mimicking neoplasm, Am. J. Roentgenol 149 (6) (1987) 1171-1172.
[7] Y. Wong, F. Chen, K.S. Tai, L.K. Yip, K.W. Tsang, F.L. Chan, et al., Imaging features of focal intrahepatic extramedullary haematopoiesis, Br. J. Radiol. 72 (861) (1999) 906-910.
[8] D.P. O’Malley, Benign extramedullary myeloid proliferations, Mod. Pathol. 20 (4) (2007) 405-415.
[9] L.J. Lowenstine, A primer of primate pathology: Lesions and nonlesions, Toxicol. Pathol. 31 (Suppl.) (2003) 92-102.
[10] L.C. Junqueira, J. Carneiro, Basic Histology: Text and Atlas, McGraw-Hill, Rio de Janeiro, 2005, pp. 238-254.
[11] Unknown, Human CD Antigen Expression-HLDA9, AbDSerotec, MorphoSys UK Ltd., Oxford, 2010.
[12] M.D. McGavin, J.F. Zachary, Pathologic basis of veterinary disease, Mosby Elsevier, St. Louis, Mo., 2007, pp. 755, 814.
[13] M.G. Maxie, K.V.F. Jubb, P.C. Kennedy, N. Palmer, Pathology of Domestic Animals, Elsevier Saunders, Edinburgh, 2007, pp. 3-289.
[14] R.H. Dunlop, C.H. Malbert, Veterinary Pathophysiology, Wiley-Blackwell, Oxford, 2004, pp. 376-377.
[15] C.E. Craig, A. Quaglia, A.P. Dhillon, Extramedullary haematopoiesis in massive hepatic necrosis, Histopathology 45 (5) (2004) 518-525.